º£½ÇÖ±²¥

>

A new class of lipid raft disruptors

By Cameron Cohen

Biological membranes are highly dynamic and varied structures which contain compact ordered domains or “rafts� of lipids and proteins within the otherwise disordered membrane “sea.� These lipid rafts serve as functional microdomains that cluster specific receptors and signaling molecules to influence membrane trafficking, signaling pathways, neurotransmission, and membrane fluidity. However, lipid raft formation and the processes which mediate ordered phase/disordered phase partitioning of biological membranes are not well understood.

Katherine Stefanski, PhD, Sanders Lab

published in PNAS, the , led by post-doctoral fellow Katherine Stefanski, aims to better characterize these mechanisms by identifying pharmacological agents which alter membrane dynamics.

The authors first conducted a high-throughput screen to identify small molecules which modulate the partitioning of human peripheral myelin protein 22 (PMP22), a protein which preferentially clusters in lipid rafts. Giant plasma membrane-derived vesicles (GPMVs) were purified out of HeLa cells expressing PMP22, exposed to a 23,360 compound library, and compounds which alter PMP22 partitioning were identified. Compounds were further screened against GPMVs from cells expressing myelin and lymphocyte protein (MAL), another lipid-raft preferring protein in order to identify nonprotein-specific small molecules. Of the compounds remaining, the researchers then identified a unique group of small molecules, specifically VU0615562 and VU0619195, which reduced the partitioning of PMP22 and MAL, disrupted lipid raft formation, and somewhat paradoxically, had increased activity in the presence of raft-favoring membrane proteins.

To validate this interesting chemical behavior, the authors exposed HeLa-cell derived GPMVs containing PMP22 or MAL to proteinase K, a serine protease which cleaves proteins, and found that the efficacy of VU0615562 and VU0619195 to disrupt lipid formation was reduced. Furthermore, GMPV radii, relative ordered domain size, and lipid symmetry were unchanged, indicating the effects of these compounds were specific to the presence of raft-favoring proteins. Both compounds, however, were shown to increase the membrane fluidity of GPMVs, with VU0619195 having a more pronounced effect than VU0615562.

Chuck Sanders, PhD
Photo by Joe Howell

The researchers then sought to determine if this behavior was the result of a direct interaction between the chemical compounds and PMP22 or MAL. NMR indicated that both VU0615562 and VU0619195 interact with PMP22, albeit weakly. To better understand the impact of this interaction, the authors then turned to another raft-favoring protein, TRPM8, an ion channel protein whose function is directly tied to membrane order. NMR also indicated that VU0619195 interacted weakly with TRPM8 and treatment of HeLa cells with VU0619195 reduced the activity of TRPM8 as seen by automated patch clamp electrophysiology.

Altogether, this study provides the first examples of a class of compounds with the unique properties of disrupting lipid formation, inhibiting protein partitioning into rafts, and exhibiting heightened activity in the presence of raft-favoring proteins. Additionally, while the compounds act in a manner enhanced by raft proteins, their activity is not totally dependent on them, making VU0615562 and VU0619195 very versatile tools for future study of lipid raft dynamics. Finally, both VU0615562 and VU0619195 were shown to be much less toxic to model cell lines than comparable compounds which will allow future researchers to study biological membranes in a much less disruptive background.

 

Explore Story Topics

Recent News